Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Keren Levanon"'
Autor:
Eva Hulstaert, Keren Levanon, Annelien Morlion, Stefan Van Aelst, Anthony-Alexander Christidis, Ruben Zamar, Jasper Anckaert, Kimberly Verniers, Keren Bahar-Shany, Stav Sapoznik, Jo Vandesompele, Pieter Mestdagh
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 24, Iss 2, Pp 155-164 (2022)
Background: Most ovarian cancer patients are diagnosed at an advanced stage and have a high mortality rate. Current screening strategies fail to improve prognosis because markers that are sensitive for early stage disease are lacking. This medical ne
Externí odkaz:
https://doaj.org/article/1167a7ed4eff480293361fff2bcb29f0
Autor:
Tomer Stern, Shira Peleg Hasson, Akram Saad, Keren Levanon, Nadav Michaan, Ido Laskov, Ido Wolf, Dan Grisaru, Tamar Safra
Publikováno v:
Gynecologic Oncology Reports, Vol 38, Iss , Pp 100863- (2021)
Objective: To examine whether patients with both breast cancer (BC) and endometrial cancer (EC) have different features of disease, and whether the sequence of appearance of these tumors is correlated with a more aggressive course. Methods: A retrosp
Externí odkaz:
https://doaj.org/article/5286d35badc04d7fb74c2b7a8a947bc1
Autor:
Einav Nili Gal-Yam, Miri Sklair-Levi, Yaeli Vachnish, Nora Balint-Lahat, Dana Morzaev-Sulzbach, Michal Bakalenik-Gavry, Renata Fearmann, Osnat Halshtok, Anat Shalmon, Michael Gotlieb, Yael Yagil, Keren Levanon, Rinat Bernstein-Molho, Amit Itay, Tali Shapira-Rotenberg, Opher Globus, Iris Barshack, Seth Salpeter, Vered Bar, Sara Aharon, Lubov Turovsky, Adi Zundelevich, Giuseppe Mallel, Hamutal Shahar, Hagit Shapira, Maya Dadiani
Publikováno v:
Cancer Research. 82:P1-08
Background. Neoadjuvant chemotherapy (NACT) is increasingly administered for high-risk breast cancer patients. Yet, oncologists lack an effective method for assessing response to treatment beyond clinicpathological features. Organ tissue slices fresh
Publikováno v:
Cancer Research. 83:P2-03
Introduction: Patients younger than 50 years old with node negative hormone receptor (HR) positive her2 negative breast cancer and oncotype Dx recurrence scores (RS) under 16 do not benefit from adjuvant chemotherapy. Those with a RS between 16-25 ma
Autor:
Opher Globus, Keren Grinin, Orit Keidar-Person, Einav Nili-Gal Yam, Keren Levanon, Naama Herman
Publikováno v:
Cancer Research. 83:P3-04
Introduction: The use of routine post-operative mammogram (RPM) in search of residual calcifications after breast conserving surgery (BCS) remains controversial due to a paucity of data and conflicting results. In our institution it is common practic
Activation-Induced Cytidine Deaminase Links Ovulation-Induced Inflammation and Serous Carcinogenesis
Autor:
Stav Sapoznik, Keren Bahar-Shany, Hadar Brand, Yishay Pinto, Orshay Gabay, Efrat Glick-Saar, Chen Dor, Oranit Zadok, Iris Barshack, Adi Zundelevich, Einav Nili Gal-Yam, Yuval Yung, Ariel Hourvitz, Jacob Korach, Mario Beiner, Jasmine Jacob, Erez Y. Levanon, Michal Barak, Sarit Aviel-Ronen, Keren Levanon
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 18, Iss 2, Pp 90-99 (2016)
In recent years, the notion that ovarian carcinoma results from ovulation-induced inflammation of the fallopian tube epithelial cells (FTECs) has gained evidence. However, the mechanistic pathway for this process has not been revealed yet. In the cur
Externí odkaz:
https://doaj.org/article/50d32a92be1b41c78b0e4e4cd7cd869a
Autor:
Yael Eshet, Noam Tau, Sara Apter, Noam Nissan, Keren Levanon, Rinat Bernstein-Molho, Ofer Globus, Amit Itay, Tal Shapira, Cecilie Oedegaard, Malka Gorfine, Michal Eifer, Tima Davidson, Einav Gal-Yam, Liran Domachevsky
Publikováno v:
Clinical Nuclear Medicine.
Autor:
Keren Bahar‐Shany, Georgina D. Barnabas, Lisa Deutsch, Netanel Deutsch, Efrat Glick‐Saar, Dan Dominissini, Stav Sapoznik, Limor Helpman, Tamar Perri, Anna Blecher, Guy Katz, Itai Yagel, Orgad Rosenblatt, Daniel Shai, Benny Brandt, Raanan Meyer, Aya Mohr‐Sasson, Alexander Volodarsky‐Perel, Itamar Zilberman, Shunit Armon, Ariella Jakobson‐Setton, Ram Eitan, Yfat Kadan, Mario Beiner, Dana Josephy, Malka Brodsky, Eitan Friedman, Liat Anafi, Yossef Molchanov, Jacob Korach, Tamar Geiger, Keren Levanon
Publikováno v:
International journal of cancerREFERENCES. 152(4)
No current screening methods for high-grade ovarian cancer (HGOC) guarantee effective early detection for high-risk women such as germline BRCA mutation carriers. Therefore, the standard-of-care remains risk-reducing salpingo-oophorectomy (RRSO) arou
Autor:
Moshit Lindzen, Diana Drago, Dan Aderka, Yosef Yarden, Keren Levanon, Nishanth Belugali Nataraj, Belinda Sánchez Ramírez, Soma Ghosh, Silvia Carvalho, Orith Leitner, Maik Dahlhoff, Iain A. McNeish, Einav Zmora, Keren Bahar Shany, Ashish Noronha, Stav Sapoznik
Publikováno v:
Oncogene
Ovarian cancer (OvCA) remains one of the most devastating malignancies, but treatment options are still limited. We report that amphiregulin (AREG) can serve as an effective and safe pharmacological target in a syngeneic murine model. AREG is highly
Publikováno v:
GYNECOLOGIC ONCOLOGY
Ovarian cancer is often diagnosed in an advanced stage and is associated with a high mortality rate. It is assumed that early detection of ovarian cancer could improve patient outcomes. Unfortunately, effective screening methods for early diagnosis o